首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs
【24h】

Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs

机译:通过体外动态脂解模型合理选择基于口服脂质的药物递送系统,以改善水溶性差的药物的口服生物利用度

获取原文
获取原文并翻译 | 示例
           

摘要

As a consequence of modern drug discovery techniques, there has been a consistent increase in the number of new pharmacologically active lipophilic compounds that are poorly water soluble. A great challenge facing the pharmaceutical scientist is making these molecules into orally administered medications with sufficient bioavailability. One of the most popular approaches to improve the oral bioavailability of these molecules is the utilization of a lipid based drug delivery system. Unfortunately, current development strategies in the area of lipid based delivery systems are mostly empirical. Hence, there is a need for a simplified in vitro method to guide the selection of a suitable lipidic vehicle composition and to rationalize the delivery system design. To address this need, a dynamic in vitro lipolysis model, which provides a very good simulation of the in vivo lipid digestion process, has been developed over the past few years. This model has been extensively used for in vitro assessment of different lipid based delivery systems, leading to enhanced understanding of the suitability of different lipids and surfactants as a delivery system for a given poorly water soluble drug candidate. A key goal in the development of the dynamic in vitro lipolysis model has been correlating the in vitro data of various drug-lipidic delivery system combinations to the resultant in vivo drug profile. In this paper, we discuss and review the need for this model, its underlying theory, practice and limitations, and the available data accumulated in the literature. Overall, the dynamic in vitro lipolysis model seems to provide highly useful initial guidelines in the development process of oral lipid based drug delivery systems for poorly water soluble drugs, and it predicts phenomena that occur in the pre-enterocyte stages of the intestinal absorption cascade. (c) 2008 Elsevier B.V. All rights reserved.
机译:作为现代药物发现技术的结果,水溶性差的新的具有药理活性的亲脂性化合物的数量一直在增加。药物科学家面临的一项巨大挑战是将这些分子制成具有足够生物利用度的口服药物。改善这些分子的口服生物利用度的最流行的方法之一是利用基于脂质的药物递送系统。不幸的是,基于脂质的递送系统领域中的当前发展策略大部分是经验性的。因此,需要一种简化的体外方法来指导合适脂质载体组合物的选择并合理化递送系统设计。为了满足这一需求,在过去的几年中,已经开发了一种动态体外脂解模型,该模型可以很好地模拟体内脂质消化过程。该模型已广泛用于体外基于不同脂质的给药系统评估,从而导致人们加深了对不同脂质和表面活性剂作为给定水溶性差的候选药物的给药系统的适用性的了解。动态体外脂解模型开发的关键目标是将各种药物-脂质递送系统组合的体外数据与所得的体内药物谱相关联。在本文中,我们讨论并审查了此模型的必要性,其基本理论,实践和局限性以及文献中积累的可用数据。总的来说,动态体外脂解模型似乎为水溶性差的药物在基于口服脂质的药物递送系统的开发过程中提供了非常有用的初始指导,并且它预测了在肠道吸收级联的前肠内细胞阶段发生的现象。 (c)2008 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号